← Back to Search

Other

New Computer Monitor for Post-Concussion Syndrome

N/A
Recruiting
Led By Charles Tator, MD, PhD
Research Sponsored by University Health Network, Toronto
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
No other neurological, psychiatric, or ocular conditions
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two visits 7 to 10 days apart
Awards & highlights

Study Summary

This trial tests if a new computer monitor is better tolerated by people with concussions, to improve understanding of concussion symptoms and help those affected.

Who is the study for?
This trial is for English-speaking adults aged 18-65 who have had concussion symptoms lasting from 1 month to 5 years. Participants must consent in writing and avoid alcohol or drugs for at least 24 hours before the intervention. Those with other neurological, psychiatric, or eye conditions cannot join.Check my eligibility
What is being tested?
The study is testing a new computer monitor designed to be better tolerated by people with post-concussion syndrome compared to standard monitors. It aims to address issues like screen intolerance and light sensitivity in concussed patients.See study design
What are the potential side effects?
Since this trial involves using a computer monitor, side effects are not typical as with medications; however, participants may experience discomfort if the screen does not alleviate their concussion-related symptoms.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I do not have any neurological, psychiatric, or eye conditions.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two visits 7 to 10 days apart
This trial's timeline: 3 weeks for screening, Varies for treatment, and two visits 7 to 10 days apart for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
The investigators believe that patients will subjectively perceive the new monitor to be a more effective reading device than the standard monitor.

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: Newly designed computer monitorExperimental Treatment1 Intervention
Participants will read a short story and then watch moving images for 30 minutes or until any of their persisting concussion symptoms arise. The number and severity of symptoms will be assessed by completing SCAT -III pre- and post-study tasks.
Group II: Standard computer monitorPlacebo Group1 Intervention
Same participants will read a short story and watch moving images for 30 minutes or until any of their persisting concussion symptoms arise on the standard computer screen.The number and severity of symptoms will be assessed by completing SCAT -III pre- and post-study tasks.

Find a Location

Who is running the clinical trial?

University Health Network, TorontoLead Sponsor
1,463 Previous Clinical Trials
483,431 Total Patients Enrolled
3 Trials studying Post-Concussion Syndrome
275 Patients Enrolled for Post-Concussion Syndrome
Charles Tator, MD, PhDPrincipal InvestigatorUniversity Health Network, Toronto
1 Previous Clinical Trials
75 Total Patients Enrolled
1 Trials studying Post-Concussion Syndrome
75 Patients Enrolled for Post-Concussion Syndrome
Carmela Tartaglia, MDPrincipal InvestigatorUniversity Health Network, Toronto
3 Previous Clinical Trials
156 Total Patients Enrolled
1 Trials studying Post-Concussion Syndrome
75 Patients Enrolled for Post-Concussion Syndrome

Media Library

New computer monitor (Other) Clinical Trial Eligibility Overview. Trial Name: NCT05660057 — N/A
Post-Concussion Syndrome Research Study Groups: Newly designed computer monitor, Standard computer monitor
Post-Concussion Syndrome Clinical Trial 2023: New computer monitor Highlights & Side Effects. Trial Name: NCT05660057 — N/A
New computer monitor (Other) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05660057 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this medical experiment offer enrollment to individuals aged twenty and older?

"The minimum age for entry into this trial is 18 and the maximum age of enrollment is 65, as stated in the prerequisites."

Answered by AI

Is this investigation recruiting new participants currently?

"As indicated by the information on clinicaltrials.gov, this medical trial is presently searching for participants. It was first made available to the public on November 7th 2022 and its details have been amended as recently as December 13th of that same year."

Answered by AI

Is it possible to join the research study at this time?

"This medical trial requires that participants have sustained a brain concussion and are aged 18 to 65. The research team seeks 100 volunteers in total for this study."

Answered by AI

What is the cap on participants in this clinical investigation?

"Affirmative. Clinicaltrials.gov's data suggests that this research project, which was initially launched on November 7th 2022, is currently recruiting participants. One hundred individuals need to be enrolled from a single medical centre."

Answered by AI
~16 spots leftby Jul 2024